Live Breaking News & Updates on Gedatolisib Clinical Trial

Stay updated with breaking news from Gedatolisib clinical trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine The

Search jobs
08-Apr-2021
Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update
Preliminary Phase 1b Data
- Gedatolisib showed a potentially differentiated safety and tolerability profile -
Corporate Update
- Proceeds from first $15 million tranche increase cash-on-hand to $44 million -
- Drug development capabilities and team broadened and expanded -
- Conference call and webcast scheduled for today, April 8 at 5 p.m. Eastern Time -
MINNEAPOLIS (BUSINESS WIRE) Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer, today reported preliminary data for the 103 patients enrolled in the expansion portion of an ongoing Phase 1b clinical trial evaluating ged ....

Sheri Smith , Bernhard Lampert , Celsignia Cdx , Arthur Decillis , Bristol Myers Squibb , Vicky Hahne , Marie Degayner Kuker , Robert Uhl , Johnr Macdonald , Brian Sullivan , Regulatory Affairs Professionals Society , Exchange Commission On , Eisai Co , Vp Clinical Research For Exelixis , University Of Georgia , Celcuity Inc , Armentum Partners , Sesen Bio Inc , Wm Pharmaceuticals , Innovatus Capital Partners , Preliminary Phase , Response Evaluation Criteria , Solid Tumors , Chief Medical , Chief Medical Officer , Senior Vice President ,

Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update

Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sheri Smith , Bernhard Lampert , Celsignia Cdx , Arthur Decillis , Bristol Myers Squibb , Vicky Hahne , Marie Degayner Kuker , Robert Uhl , Johnr Macdonald , Brian Sullivan , Regulatory Affairs Professionals Society , Exchange Commission On , Eisai Co , Vp Clinical Research For Exelixis , University Of Georgia , Celcuity Inc , Armentum Partners , Sesen Bio Inc , Wm Pharmaceuticals , Innovatus Capital Partners , Wall Street , Response Evaluation Criteria , Solid Tumors , Chief Medical , Chief Medical Officer , Senior Vice President ,